Medicine and Dentistry
Lafora Disease
100%
Disease
96%
Spinal Muscular Atrophy
65%
Pediatrics
64%
Apoplexy
56%
Epileptic Seizure
50%
Brain Ischemia
36%
Duchenne Muscular Dystrophy
31%
Neurologic Disease
30%
Clinical Trial
28%
Gene Therapy
27%
Symptom
27%
Pediatric Stroke
24%
Sickle-Cell Disease
20%
Genetic Screening
19%
Pediatric Epilepsy
19%
Pediatrics Patient
18%
Diagnosis
18%
Neuromuscular Disease
17%
Myopathy
17%
Magnetic Resonance Imaging
16%
Adeno-Associated Virus
15%
Serotype
15%
Artery Disease
14%
Ataxia
14%
Batten Disease
14%
Infection
13%
Status Epilepticus
13%
Autophagy
13%
Brain Infarction
12%
Quality of Life
12%
Muscular Dystrophy
12%
Epilepsy Surgery
12%
Prevalence
12%
Giant Axonal Neuropathy
12%
Motor Performance
11%
Brain Disease
11%
Drug Therapy
11%
Electroencephalogram
11%
Adeno Associated Virus Vector
11%
Drug Megadose
11%
Infantile Spasm
10%
Clinical Feature
10%
Biological Marker
10%
Biopsy
10%
Neurology
9%
Myoclonus
9%
Disease Course
9%
Disease Exacerbation
9%
Neonate
9%
Adenosine Triphosphatase
9%
In Vitro
8%
Dystrophin
8%
DeJerine-Sottas Disease
8%
COVID-19
8%
Odds Ratio
7%
Rett Syndrome
7%
Systematic Review
7%
Skeletal Muscle
7%
Weakness
7%
Epilepsy Syndromes
7%
Recurrent Disease
7%
Chorea
7%
Glycogen Synthase
7%
Onasemnogene Abeparvovec
7%
Nusinersen
7%
Hypotonia
7%
Genetic Disorder
7%
Combination Therapy
7%
Clinical Research
7%
Werdnig Hoffmann Disease
6%
Adverse Event
6%
Lifespan
6%
Epileptic Absence
6%
Stereotypic Movement Disorder
6%
Vacuolization
6%
Neurodegeneration
6%
Maturation
6%
Spinal Muscular Atrophy Type 2
6%
Spastic Diplegia
6%
Glycogen Synthesis
6%
Pervasive Developmental Disorder
6%
Intractable Epilepsy
6%
Brainstem
6%
Clinician
6%
National Institutes of Health Stroke Scale
6%
Transgene
5%
Intrathecal Drug Administration
5%
Neuropathy
5%
Autosomal Recessive Inheritance
5%
Anemia
5%
Myasthenia gravis
5%
Antisense Therapy
5%
Health Care Cost
5%
Neurologic Examination
5%
Blood Clot Lysis
5%
Onset Age
5%
Injury
5%
Dystonia
5%
Genotype Phenotype Correlation
5%
Neuroscience
Myoclonus
60%
Adeno-Associated Virus
39%
Muscular Dystrophy
33%
Dystonia
29%
Encephalopathy
28%
Central Nervous System
26%
Muscle Disorder
25%
Brain Ischemia
25%
Spinal Muscular Atrophy
25%
Epileptic Absence
25%
Intrathecal
24%
Adeno Associated Virus Vector
23%
Rett Syndrome
22%
Stereotypic Movement Disorder
22%
Gene Transfer
21%
Ataxia
20%
Glycogen Synthase
19%
Pervasive Developmental Disorder
19%
Neurodegeneration
18%
Peripheral Neuropathy
18%
Nervous System Disorder
18%
Neurological Disorder
17%
Hypotonia
17%
Metabolic Pathway
16%
Exon
15%
Cerebral Infarction
14%
Neurodegenerative Disorder
14%
Skeletal Muscle
13%
Magnetic Resonance Imaging
13%
In Vivo
13%
Magnetic Resonance Imaging
13%
MECP2
13%
Pediatric Epilepsy
11%
Dystrophin
11%
Angelman Syndrome
11%
Electroencephalogram
11%
Concussion
11%
Parkinsonism
11%
Motor Neuron
11%
Gene Delivery
11%
Electroencephalography
11%
Neuronal Ceroid Lipofuscinosis
10%
Status Epilepticus
9%
Synapse
9%
Ubiquitin Protein Ligase E3
9%
Galactosylceramidase
9%
Intractable Epilepsy
9%
Krabbe Disease
9%
Autophagy
8%
Cerebral Hemorrhage
8%
1,4 Alpha Glucan Branching Enzyme
8%
Virus Gene
8%
Gene Expression
8%
Promoter Region
8%
Learning Disabilities
8%
Dendrite
7%
N4 (Beta N Acetylglucosaminyl)asparaginase
7%
Transgene
7%
Encephalitis
7%
Ictal
7%
Endoplasmic reticulum
7%
Focal Epilepsy
7%
Dravet Syndrome
7%
Eicosanoid Receptor
7%
Protein Tyrosine Phosphatase
7%
Neuroscience
7%
Cerebral Palsy
7%
Headache
7%
Behavior (Neuroscience)
7%
Parkinson's Disease
7%
Basal Ganglia
7%
Phosphatase
7%
Neuromuscular Disorder
6%
Behavior Disorder
6%
Methyl CpG Binding Protein 2
6%
Ceroid
6%
Virus Vector
6%
Creatine Kinase
6%
Traumatic Brain Injury
6%
Neurotrauma
6%
Vertebral Artery
6%
Ketogenic Diet
6%
Leukodystrophy
6%
Feeding Behavior
6%
Brain Development
6%
Autonomic Nervous System
6%
Oligodendrocyte
6%
Cognitive Disorders
6%
Fragile X Syndrome
6%
Cell Culture
6%
Electroencephalography
5%
Myasthenia gravis
5%
Citric Acid Cycle
5%
Glucose Transporter 1
5%
In Vitro
5%
Peripheral Nervous System
5%
Glycogenesis
5%
Whole Genome Sequencing
5%
Striatum
5%
Putamen
5%
Keyphrases
Lafora Disease
51%
Gene Therapy
39%
Progressive Myoclonus Epilepsy
34%
Spinal muscular Atrophy
29%
Epilepsy
28%
Seizure
28%
Duchenne muscular Dystrophy
24%
Glycogen
24%
Laforin
22%
Pediatric
16%
Lafora Bodies
16%
Malin
15%
Mouse Model
12%
Neuromuscular Disease
12%
EPM2A
12%
SLC6A1
12%
Neurodevelopmental Disorders
11%
Neuronal Ceroid Lipofuscinosis
11%
Rett Syndrome
11%
Methyl-CpG-binding Protein 2 (MeCP2)
10%
Central Nervous System
10%
EPM2B
10%
Vitamin E Deficiency
10%
Intrathecal
10%
AAV9
10%
Drug Treatment
9%
Giant Axonal Neuropathy
9%
Lafora
9%
Skeletal muscle
9%
Neurodegeneration
8%
Myoclonus
8%
Sickle Cell Anemia
8%
Autosomal Recessive
8%
X-linked Myopathy with Excessive Autophagy
8%
Developmental Delay
8%
Congenital Myopathy
8%
GM2 Gangliosidosis
8%
Ataluren
8%
Spinal muscular Atrophy Type I
8%
Neurodegenerative Diseases
7%
Polyglucosan
7%
Intrafamilial Variability
7%
Nonsense mutation Duchenne muscular Dystrophy
7%
Neurological Disorders
7%
Intellectual Disability
7%
Genetic Testing
7%
Cystatin B
7%
Non-progressive
7%
Onasemnogene Abeparvovec
7%
Nusinersen
7%
Nemaline Myopathy
7%
Functional Neurological Disorder
7%
Gene Transfer
7%
Glycogen Synthase
6%
Pediatric Stroke
6%
Clinical Trials
6%
Confidence Interval
6%
Vitamin E
6%
Glycogen Metabolism
6%
GM2 Ganglioside
6%
Phosphatase
6%
ATN1
6%
Protein Tyrosine Phosphatase 1B (PTP1B)
6%
Globoid Cell Leukodystrophy
6%
Immune Response
6%
Adeno-associated Viral Vector
6%
Neonate
5%
Hypotonia
5%
Etiology
5%
NHLRC1
5%
Myopathy
5%
Non-coding
5%
Spinal muscular Atrophy Type III
5%
Spinal muscular Atrophy Type II
5%
Congenital Myasthenic Syndrome
5%
Prednisone
5%
Placebo
5%
E3 Ubiquitin Ligase
5%
Lysosomal Storage Disease
5%
Clinical Characteristics
5%
Clinical Translation
5%
Treatment Strategy
5%
Adeno-associated Viral
5%
Gigaxonin
5%
Tolerability
5%
Aspartylglucosaminuria
5%
Prednisolone
5%
VMA21
5%
Adeno-associated Virus Serotype 9
5%
Viral Vectors
5%
Batten Disease
5%
Serum Vitamin E
5%
Deflazacort
5%
AB Variant
5%
High Dose
5%
Infantile Spasms
5%
Movement Disorders
5%
Monogenic
5%
Genotype-phenotype Correlation
5%
Cerebral Palsy
5%